The contractor shall support the administrative and technical activities conducted on a recurring basis to provide quality assurance/quality control (QA/QC) support to task orders awarded under task…
Ended Awarded Last action
- Contract number
- 75N93019F00132
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,109,777
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2015029 Solicitation number
- Comprehensive Resources for HIV Microbicides and Biomedical Prevention Award Notice · Posted Jun 24, 2015
- Contract value 71% obligated
-
- $2,109,777.08 Current, with exercised options
- $2,978,600.08 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$42,387 | |
| Funding Only Action | $23,892 | |
| Exercise an Option | $527,994 | |
| Exercise an Option | $511,030 | |
| Exercise an Option | $494,377 | |
| Exercise an Option | $117,127 | |
| Original award | $477,744 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL) on July 15, 2019. The contract has a ceiling value of $2,978,600.08 and a period of performance through September 27, 2024.
The contract supports the administrative and technical activities conducted on a recurring basis to provide quality assurance/quality control (QA/QC) support to task orders awarded under Task Areas A, B, C, and D of the "HIV Microbicides and Biomedical Prevention 2016-2021" contract vehicle. This contract vehicle is not set aside for any specific business size or socioeconomic status. ABL, a large for-profit manufacturer of goods, has been awarded numerous federal contracts and grants, particularly from NIH and the Department of Health and Human Services, to advance the development of medical countermeasures for various infectious diseases.
Description
The contractor shall support the administrative and technical activities conducted on a recurring basis to provide quality assurance/quality control (QA/QC) support to task orders awarded under task areas a, b, c, and d.
Quick answers
Who was awarded contract 75N93019F00132?
75N93019F00132 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2019.
How much is contract 75N93019F00132 worth?
The government has obligated $2,109,777 on 75N93019F00132. Its potential value, with all options, is $2,978,600.
Is contract 75N93019F00132 an order under another contract?
Yes. 75N93019F00132 is a delivery order under HHSN272201600008I, an indefinite delivery contract, on HIV Microbicides and Biomedical Prevention 2016-2021.
Was contract 75N93019F00132 competed?
The extent of competition for 75N93019F00132 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award